Undifferentiated Carcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer
Condition: Anaplastic Thyroid CancerIntervention: Drug: PembrolizumabSponsors: University of Texas Southwestern Medical Center; Merck Sharp & Dohme Corp.Not yet recruiting - verified February 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 20, 2016 Category: Research Source Type: clinical trials

Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
Conditions: Recurrent Thyroid Gland Carcinoma; Stage III Differentiated Thyroid Gland Carcinoma; Stage III Thyroid Gland Medullary Carcinoma; Stage IVA Differentiated Thyroid Gland Carcinoma; Stage IVA Thyroid Gland Medullary Carcinoma; Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma; Stage IVB Differentiated Thyroid Gland Carcinoma; Stage IVB Thyroid Gland Medullary Carcinoma; Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma; Stage IVC Differentiated Thyroid Gland Carcinoma; Stage IVC Thyroid Gland Medullary Carcino...
Source: ClinicalTrials.gov - October 14, 2015 Category: Research Source Type: clinical trials